ARTELO BIOSCIENCES, INC. 8-K filing
Filed 2026-03-17 · Report date 2026-03-17 · 2026
Filing metadata
- Accession number
- 0001640334-26-000461
- Form type
- 8-K
- CIK
- 0001621221
- Primary document
- https://www.sec.gov/Archives/edgar/data/1621221/000164033426000461/artl_8k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ARTELO BIOSCIENCES, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-11.4M | - | - |
| Net Income | $-12.9M | - | - |
| Eps Diluted | -37.75 | - | - |
| Cash And Equivalents | $600,000 | - | - |
| Total Assets | $2.8M | - | - |
| Total Liabilities | $4.1M | - | - |
| Shareholders Equity | $-1.3M | - | - |
| Operating Cash Flow | $-8.5M | - | - |